Immunological response in mice bearing LM3 breast tumor undergoing Pulchellin treatment

• Autors principals: de Matos Djamile (Autor), de Ribeiro Lívia Carolina (Autor), Tansini Aline (Autor), Ferreira Lucas (Autor), Placeres Marisa Campos (Autor), Colombo Lucas (Autor), Carlos Iracilda (Autor)
• Format: Llibre
• Publicat: BMC, 2012-07-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>Ribosome-inactivating proteins (RIP) have been studied in the search for toxins that could be used as immunotoxins for cancer treatment. Pulchellin, a type 2 RIP, is suggested to induce immune responses that have a role in controllin...